{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:12:36Z","timestamp":1770448356405,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.iac.2016.06.002","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T19:22:48Z","timestamp":1473880968000},"page":"643-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Donald D.","family":"Stevenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2016.06.002_bib1","first-page":"189","article-title":"Anaphylaxie et idiosyncrasie","volume":"30","author":"Widal","year":"1922","journal-title":"Presse Med"},{"issue":"5","key":"10.1016\/j.iac.2016.06.002_bib2","first-page":"281","article-title":"Concerning the nature of intolerance to aspirin","volume":"40","author":"Samter","year":"1967","journal-title":"J\u00a0Allergy"},{"issue":"3","key":"10.1016\/j.iac.2016.06.002_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7326\/0003-4819-66-3-568","article-title":"Bronchial asthma induced by indomethacin","volume":"66","author":"Vanselow","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.iac.2016.06.002_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2500\/108854193778773985","article-title":"Widal on the aspirin triad and induction of tolerance","volume":"14","author":"Klion","year":"1993","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.iac.2016.06.002_bib5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin. Clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.iac.2016.06.002_bib6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1398-9995.2011.02557.x","article-title":"Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI\/ENDA and GA2LEN\/HANNA","volume":"66","author":"Kowalski","year":"2011","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.iac.2016.06.002_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2016.06.002_bib8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.iac.2016.06.002_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.intimp.2015.05.035","article-title":"Natural helper cells contribute to pulmonary eosinophilia by producing IL-13 via IL-33\/ST2 pathway in a murine model of respiratory syncytial virus infection","volume":"28","author":"Liu","year":"2015","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.iac.2016.06.002_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1165\/rcmb.2014-0068OC","article-title":"Rhinovirus infection induces interleukin-13 production from CD11b-positive, M2-polarized exudative macrophages","volume":"52","author":"Chung","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.iac.2016.06.002_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.anai.2011.09.022","article-title":"Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease","volume":"108","author":"Chang","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2016.06.002_bib12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","article-title":"Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma","volume":"116","author":"Mascia","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2016.06.002_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0091-6749(83)90440-2","article-title":"Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration","volume":"71","author":"Lumry","year":"1983","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2016.06.002_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0091-6749(83)90439-6","article-title":"Aspirin-sensitive rhinosinusitis\/asthma: spectrum of adverse reactions to aspirin","volume":"71","author":"Pleskow","year":"1983","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2016.06.002_bib15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1081-1206(10)61150-7","article-title":"The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease","volume":"95","author":"White","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2016.06.002_bib16","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1081-1206(10)61101-5","article-title":"Effect of leukotriene modifier drugs on the safety of oral aspirin challenges","volume":"97","author":"White","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2016.06.002_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2500\/aap.2013.34.3670","article-title":"The clinical dilemma of \u201csilent desensitization\u201d in aspirin-exacerbated respiratory disease","volume":"34","author":"White","year":"2013","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.iac.2016.06.002_bib18","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.2500\/ajra.2012.26.3738","article-title":"Aspirin-exacerbated respiratory disease in China: a cohort investigation and literature review","volume":"26","author":"Fan","year":"2012","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"10.1016\/j.iac.2016.06.002_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2016.06.002_bib20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/014556130708600715","article-title":"The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery","volume":"86","author":"Kim","year":"2007","journal-title":"Ear Nose Throat J"},{"issue":"1","key":"10.1016\/j.iac.2016.06.002_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2013.07.004","article-title":"Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis","volume":"133","author":"Bochenek","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2016.06.002_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/iid3.46","article-title":"A\u00a0retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men","volume":"3","author":"Stevens","year":"2015","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.iac.2016.06.002_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2015.11.031","article-title":"African American Patients With Chronic Rhinosinusitis Have a Distinct Phenotype of Polyposis Associated With Increased Asthma Hospitalization","author":"Mahdavinia","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5949","key":"10.1016\/j.iac.2016.06.002_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/bmj.1.5949.67","article-title":"Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients","volume":"1","author":"Szczeklik","year":"1975","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.iac.2016.06.002_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0091-6749(89)90174-7","article-title":"Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma","volume":"84","author":"Settipane","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2016.06.002_bib26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0091-6749(05)80179-4","article-title":"Salsalate cross-sensitivity in aspirin-sensitive patients with asthma","volume":"86","author":"Stevenson","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.iac.2016.06.002_bib27","first-page":"393","article-title":"Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs.","volume":"35","author":"Senna","year":"2003","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"1 Pt 2","key":"10.1016\/j.iac.2016.06.002_bib28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0091-6749(86)90011-4","article-title":"Adverse reactions to tartrazine","volume":"78","author":"Stevenson","year":"1986","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.002_bib29","series-title":"Food allergy: adverse reactions to foods and food additives","first-page":"377","article-title":"Tartrazine, Azo and Non-Azo Dyes","author":"Stevenson","year":"2008"},{"issue":"2 Pt 1","key":"10.1016\/j.iac.2016.06.002_bib30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0091-6749(99)70371-4","article-title":"Monosodium glutamate sensitivity in asthma","volume":"104","author":"Woessner","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2016.06.002_bib31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2008.09.048","article-title":"Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease","volume":"123","author":"Hope","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2016.06.002_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2016.06.002_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaci.2007.03.020","article-title":"The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges","volume":"120","author":"Williams","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2016.06.002_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2500\/ajr.2007.21.2909","article-title":"Intracranial polyps in patients with Samter's triad","volume":"21","author":"Majithia","year":"2007","journal-title":"Am J Rhinol"},{"issue":"5","key":"10.1016\/j.iac.2016.06.002_bib35","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/MAO.0b013e318259522f","article-title":"Aural polyps in Samter's triad: case report and literature review","volume":"33","author":"Shen","year":"2012","journal-title":"Otol Neurotol"},{"issue":"6","key":"10.1016\/j.iac.2016.06.002_bib36","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1081-1206(10)61323-3","article-title":"Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease","volume":"94","author":"Mascia","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.iac.2016.06.002_bib37","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jaip.2015.06.018","article-title":"Symptom-based clustering in chronic rhinosinusitis relates to history of aspirin sensitivity and postsurgical outcomes","volume":"3","author":"Divekar","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.iac.2016.06.002_bib38","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jaip.2015.03.001","article-title":"Survey-defined patient experiences with aspirin-exacerbated respiratory disease","volume":"3","author":"Ta","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.iac.2016.06.002_bib39","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/all.12629","article-title":"NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity","volume":"70","author":"Morales","year":"2015","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2016.06.002_bib40","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1378\/chest.07-0713","article-title":"Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study","volume":"132","author":"Lee","year":"2007","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.iac.2016.06.002_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1183\/09031936.93.02020127","article-title":"Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation","volume":"2","author":"Picado","year":"1989","journal-title":"Eur\u00a0Respir J"},{"issue":"5","key":"10.1016\/j.iac.2016.06.002_bib42","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.rmed.2015.02.015","article-title":"Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease","volume":"109","author":"Bochenek","year":"2015","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.iac.2016.06.002_bib43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","article-title":"Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"111","author":"Berges-Gimeno","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2016.06.002_bib44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/thorax.57.7.569","article-title":"The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients","volume":"57","author":"Vally","year":"2002","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.iac.2016.06.002_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000189195","article-title":"Increases in urinary 9alpha,11beta-prostaglandin f2 indicate mast cell activation in wine-induced asthma","volume":"149","author":"Misso","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2016.06.002_bib46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaip.2013.12.003","article-title":"Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease","volume":"2","author":"Cardet","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2016.06.002_bib47","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ajpath.2012.05.020","article-title":"Acute oral ethanol exposure triggers asthma in cockroach allergen-sensitized mice","volume":"181","author":"Bouchard","year":"2012","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.iac.2016.06.002_bib48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.anai.2015.02.013","article-title":"Resolution of alcohol-induced respiratory symptoms following aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"114","author":"Calais","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2016.06.002_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2500\/ajra.2014.28.4054","article-title":"Elevated total serum IgE in nonatopic patients with aspirin-exacerbated respiratory disease","volume":"28","author":"Johns","year":"2014","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"10.1016\/j.iac.2016.06.002_bib50","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000353976","article-title":"Clinical significance of immunoglobulin E responses to staphylococcal superantigens in patients with aspirin-exacerbated respiratory disease","volume":"162","author":"Yoo","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.iac.2016.06.002_bib51","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaip.2015.01.007","article-title":"Tolerance of daily low-dose aspirin does not preclude aspirin-exacerbated respiratory disease","volume":"3","author":"Lee-Sarwar","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856116300479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856116300479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T03:33:38Z","timestamp":1692502418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856116300479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0889856116300479"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2016.06.002","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2016.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}